(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 5.94% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Aptargroup's revenue in 2025 is $3,573,282,000.On average, 4 Wall Street analysts forecast ATR's revenue for 2025 to be $250,481,576,832, with the lowest ATR revenue forecast at $246,808,921,668, and the highest ATR revenue forecast at $255,412,964,152. On average, 3 Wall Street analysts forecast ATR's revenue for 2026 to be $264,717,906,709, with the lowest ATR revenue forecast at $260,816,276,214, and the highest ATR revenue forecast at $271,090,554,323.
In 2027, ATR is forecast to generate $287,194,021,307 in revenue, with the lowest revenue forecast at $287,194,021,307 and the highest revenue forecast at $287,194,021,307.